Replies to post #21919 on Regen BioPharma Inc (RGBP)

[cvinvestor]

You're right, only 83.9M shares in float. Had my last 2 numbers reversed. Sorry. As far a who can be selling, for those of us posting over the last 2 years, we've extensively documented the pattern and history of convertible notes, registered/unregistered shares, incentive shares and the like which can all be found in the 8Ks filed by the company.

2015 has had its great promise and much more advancement in the science and company patents and collaborative efforts of outside entities, which all give hope for the future. The key point now to where price goes in my opinion in directly related to how RGBP raises its funds. I have consistently posted on that. "Angel investors" and Koos himself received convertible notes from Feb-May 2015 for the most part with March loans attached to convertible notes being the heaviest. Those loans where all immediately converted into shares (30 million plus total) that are released at a rate of 1/6th every month beginning on the 6th month from issue (Sept). On December 17th, another 5 million shares will be released.

Here's what TDA has on RGBP shares:

Historic Growth and Share Detail

Historic Growth
No historic growth available.

Short Interest
No short interest available.

Share Information
RGBP is in a share class of common stock
Float 83.9 MShares

Outstanding 113.9M

Institutions Holding Shares--% Held by Institutions--

89.3M Float. You are making some wild comments about the selling of shares and who's selling. Unless you can prove those accusations you may want to put away the coffee.

Cheers!!!